Associate Director

Flagship Pioneering

Flagship Pioneering

501-1,000 employees

Originates biotech ventures for health and sustainability

Venture Capital


Cambridge, MA, USA

  • S. in Biological/Chemical Sciences, or relative science. Advanced degree (Ph.D. or MBA) desirable.
  • 4-6 years' experience with scientific operations and/or portfolio/program management experience in biotech/pharma industry.
  • Extensive R&D experience in pharma/biotech industry.
  • Experience in working in a multi-disciplinary/matrix environment.
  • Knowledge of early drug discovery process through IND.
  • Excellent verbal and written communication skills.
  • Ability to work in a fast-paced environment.
  • Experience with time management/tracking, using timeline management programs (Excel, Smartsheet, ThinkCell etc.).
  • M.S. or Ph.D. in biological sciences or related field.
  • Partner with Program Leadership to establish program strategy and associated program plans.
  • Responsible for creating execution strategies for the operational objectives, including timelines/milestones, and deliverables.
  • Partner with Program Lead to develop acceleration opportunities for various milestones, risk/benefit assessments, and risk mitigation plans.
  • Work with CROs to establish work plans, timelines, and tracking their deliverables.
  • Work collaboratively with cross-functional teams to create a sense of urgency; proactively identify potential future challenges for the program and look for solutions.
  • Develop communication strategies and present the progress to senior management.
  • Create and track programs budget.
  • Support alliance collaborations as needed.

Flagship Pioneering stands out as a leader in the biotechnology industry, having originated and nurtured over 100 scientific ventures, including high-profile companies like Moderna and Indigo Agriculture. The company's culture is rooted in developing transformative products for human health and sustainability, as evidenced by their creation of platform companies like Generate Biomedicines and Tessera Therapeutics. Their competitive edge lies in their ability to explore new frontiers in genetics, as demonstrated by their recent unveiling of Quotient Therapeutics, a venture aimed at creating transformative medicines.

Company Stage


Total Funding



Cambridge, Massachusetts



Growth & Insights

6 month growth


1 year growth


2 year growth